Convergent Neuroimaging and Molecular Signatures in Mild Cognitive Impairment and Alzheimer's Disease: A Data-Driven Meta-Analysis with N=3,118
文献类型：期刊论文
| 作者 | Kang, Xiaopeng1,2,3; Wang, Dawei4; Lin, Jiaji5,6; Yao, Hongxiang7; Zhao, Kun8 ; Song, Chengyuan9; Chen, Pindong1,2,3; Qu, Yida1,2,3; Yang, Hongwei10; Zhang, Zengqiang11
|
| 刊名 | NEUROSCIENCE BULLETIN
 |
| 出版日期 | 2024-06-01 |
| 页码 | 13 |
| 关键词 | Alzheimer's disease Structural magnetic resonance imaging Meta-analysis Brain atrophy Gene set enrichment analysis |
| ISSN号 | 1673-7067 |
| DOI | 10.1007/s12264-024-01218-x |
| 通讯作者 | Han, Ying(hanying@xwh.ccmu.edu.cn) ; Liu, Yong(yongliu@bupt.edu.cn) |
| 英文摘要 | The current study aimed to evaluate the susceptibility to regional brain atrophy and its biological mechanism in Alzheimer's disease (AD). We conducted data-driven meta-analyses to combine 3,118 structural magnetic resonance images from three datasets to obtain robust atrophy patterns. Then we introduced a set of radiogenomic analyses to investigate the biological basis of the atrophy patterns in AD. Our results showed that the hippocampus and amygdala exhibit the most severe atrophy, followed by the temporal, frontal, and occipital lobes in mild cognitive impairment (MCI) and AD. The extent of atrophy in MCI was less severe than that in AD. A series of biological processes related to the glutamate signaling pathway, cellular stress response, and synapse structure and function were investigated through gene set enrichment analysis. Our study contributes to understanding the manifestations of atrophy and a deeper understanding of the pathophysiological processes that contribute to atrophy, providing new insight for further clinical research on AD. |
| WOS关键词 | UNFOLDED PROTEIN RESPONSE ; HIPPOCAMPAL NEURONAL LOSS ; 5-HT1A RECEPTORS ; CORTICAL THICKNESS ; MATTER LOSS ; DEMENTIA ; ATROPHY ; BRAIN ; MRI ; MECHANISMS |
| 资助项目 | Science and Technology Innovation[2022ZD0211600] ; Fundamental Research Funds for the Central Universities[2021XD-A03] ; National Natural Science Foundation of China[61633018] ; National Natural Science Foundation of China[81571062] ; National Natural Science Foundation of China[81400890] ; National Natural Science Foundation of China[81471120] ; National Natural Science Foundation of China[81701781] ; National Natural Science Foundation of China[81901101] ; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)[U01 AG024904] ; DOD ADNI (Department of Defense)[W81XWH-12-2-0012] ; National Institute on Aging ; National Institute of Biomedical Imaging and Bioengineering ; Alzheimer's Association ; Alzheimer's Drug Discovery Foundation ; Araclon Biotech ; Biogen ; CereSpir, Inc. ; Cogstate ; Elan Pharmaceuticals, Inc. ; EuroImmun ; F. Hoffmann-La Roche Ltd ; Fujirebio ; IXICO Ltd. ; Johnson & Johnson Pharmaceutical Research & Development LLC. ; Merck Co., Inc. ; Meso Scale Diagnostics ; NeuroRx Research ; Pfizer Inc. ; Piramal Imaging ; Canadian Institutes of Health Research ; ADNI clinical sites in Canada ; Foundation for the National Institutes of Health ; Northern California Institute for Research and Education ; Laboratory for Neuro Imaging at the University of Southern California |
| WOS研究方向 | Neurosciences & Neurology |
| 语种 | 英语 |
| WOS记录号 | WOS:001236799700001 |
| 出版者 | SPRINGER |
| 资助机构 | Science and Technology Innovation ; Fundamental Research Funds for the Central Universities ; National Natural Science Foundation of China ; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) ; DOD ADNI (Department of Defense) ; National Institute on Aging ; National Institute of Biomedical Imaging and Bioengineering ; Alzheimer's Association ; Alzheimer's Drug Discovery Foundation ; Araclon Biotech ; Biogen ; CereSpir, Inc. ; Cogstate ; Elan Pharmaceuticals, Inc. ; EuroImmun ; F. Hoffmann-La Roche Ltd ; Fujirebio ; IXICO Ltd. ; Johnson & Johnson Pharmaceutical Research & Development LLC. ; Merck Co., Inc. ; Meso Scale Diagnostics ; NeuroRx Research ; Pfizer Inc. ; Piramal Imaging ; Canadian Institutes of Health Research ; ADNI clinical sites in Canada ; Foundation for the National Institutes of Health ; Northern California Institute for Research and Education ; Laboratory for Neuro Imaging at the University of Southern California |
| 源URL | [http://ir.ia.ac.cn/handle/173211/58692]  |
| 专题 | 自动化研究所_脑网络组研究中心 |
| 通讯作者 | Han, Ying; Liu, Yong |
| 作者单位 | 1.Univ Chinese Acad Sci, Sch Artificial Intelligence, Beijing 100049, Peoples R China 2.Chinese Acad Sci, Inst Automat, Brainnetome Ctr, Beijing 100190, Peoples R China 3.Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing 100190, Peoples R China 4.Shandong Univ, Dept Radiol, Qilu Hosp, Jinan 250063, Peoples R China 5.Air Force Med Univ, Affiliated Hosp 2, Dept Neurol, Xian 710032, Peoples R China 6.Chinese Peoples Liberat Army Gen Hosp, Dept Radiol, Beijing 100853, Peoples R China 7.Chinese Peoples Liberat Army Gen Hosp, Med Ctr 2, Natl Clin Res Ctr Geriatr Dis, Dept Radiol, Beijing 100853, Peoples R China 8.Beijing Univ Posts & Telecommun, Sch Artificial Intelligence, Beijing 100191, Peoples R China 9.Shandong Univ, Dept Neurol, Qilu Hosp, Jinan 250063, Peoples R China 10.Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing 100053, Peoples R China |
| 推荐引用方式 GB/T 7714 | Kang, Xiaopeng,Wang, Dawei,Lin, Jiaji,et al. Convergent Neuroimaging and Molecular Signatures in Mild Cognitive Impairment and Alzheimer's Disease: A Data-Driven Meta-Analysis with N=3,118[J]. NEUROSCIENCE BULLETIN,2024:13. |
| APA | Kang, Xiaopeng.,Wang, Dawei.,Lin, Jiaji.,Yao, Hongxiang.,Zhao, Kun.,...&Liu, Yong.(2024).Convergent Neuroimaging and Molecular Signatures in Mild Cognitive Impairment and Alzheimer's Disease: A Data-Driven Meta-Analysis with N=3,118.NEUROSCIENCE BULLETIN,13. |
| MLA | Kang, Xiaopeng,et al."Convergent Neuroimaging and Molecular Signatures in Mild Cognitive Impairment and Alzheimer's Disease: A Data-Driven Meta-Analysis with N=3,118".NEUROSCIENCE BULLETIN (2024):13. |
入库方式： OAI收割
来源：自动化研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。